The effects of safinamide according to gender in Chinese parkinsonian patients

The incidence and prevalence of Parkinson’s disease (PD) is expected to raise dramatically over the next decades. Gender-related differences are not yet widely recognized, particularly regarding the response to dopaminergic medications. To analyse gender differences in the clinical effects of safina...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellecchia, M. T., Picillo, M., Russillo, M. C., Andreozzi, V., Oliveros, C., Cattaneo, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667246/
https://www.ncbi.nlm.nih.gov/pubmed/37996493
http://dx.doi.org/10.1038/s41598-023-48067-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667246/
https://www.ncbi.nlm.nih.gov/pubmed/37996493
http://dx.doi.org/10.1038/s41598-023-48067-8

Ejemplares similares